Pfizer Inc. investors are pushing for a spinoff of the drugmaker's nutrition business that would command a price tag of $6.8 billion and deliver more than twice the gains of the U.S. stock market.
More...
Toggle signature
||||| Mentor Group Access Now! |||||
More...
Toggle signature
||||| Mentor Group Access Now! |||||